This is the authors' abstract. We don't add key points for this paper.
Near-infrared (NIR) electroluminescence at 1.54 μm is vital for optical communication and bioimaging. Although CsPbCl3:Yb3+, Er3+ perovskite quantum dots (PQDs) represent a promising emitter platform, their device efficiency is hindered by intrinsically weak Er3+ emission. Here, we achieve highly efficient 1.54 μm electroluminescence via a bulk-surface dual-reconstruction strategy. Within the lattice interior, Na+ incorporation fills Pb vacancies and perturbs local crystal-field symmetry, suppressing non-radiative decay while enhancing the Er3+ and Yb3+ radiative transition rates by 7.83-fold and 3.30-fold, respectively. This boosts the Yb3+-to-Er3+ energy transfer efficiency from 15% to 56.6%. Concurrently, at the PQD surface, passivation with trifluoromethanesulfonate (OTF-) eliminates halogen vacancies via robust Lewis acid--base coordination, yielding a 45% photoluminescence quantum yield (PLQYs) at 1.54 μm. Consequently, the optimized NIR perovskite light-emitting diodes deliver a 3.27% external quantum efficiency, a 2.03 mW sr–1 cm–2 peak radiance, and an operational half-life exceeding 120 min.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: